Incannex Healthcare Missed Consensus Estimates

Incannex Healthcare (IXHL) reported a loss of $0.14 per share on revenue of $0.00 million for the fiscal fourth quarter ended June 2026. The consensus earnings estimate was $0.13 per share. The company missed consensus estimates by 207.69%.

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.